In view of the considerable current interest and research involving the vascular endothelium, the Section of Pathology organized a meeting to review this subject. Professor J Pearson (King's College, London) opened the symposium with an overview of vascular endothelial function in health and disease. It was emphasized that the endothelium synthesizes and secretes a plethora of potent substances that inhibit platelet and leukocyte adhesion, control vasoactivity, influence cell proliferation, initiate the coagulation/fibrinolytic cascades, and control leukocyte infiltration and extravasation. Among these substances are nitric oxide, prostacyclin, von Willebrand factor, tissue plasminogen activator, endothelin and adhesion molecules. In turn, if normal endothelial function is compromised (e.g. by risk factors), then this may lead to events associated with atherogenesis and thrombosis through disruption of these endothelial factors. The evidence for alterations of these factors in (cardiovascular disease was summarized thus effectively s~,tti ng the scene for the rest of the meeting.
Professor M J Davies (St George's Hospital Medical
School, London) discussed the importance of the fragility of human atherosclerotic plaques with the help of elegant histopathology slides. It was shown that the atherosclerotic plaque in the coronary artery consists principally of a lipid core (of varying size) which is surrounded by fibrous tissue (of varying thickness). When the cap of the plaque, the portion of the lesion that projects into the lumen of the artery, ruptures, platelets aggregate and a thrombus ensues. Histology also shows that thrombi appear within the 'cavernous' portions of the plaque, following rupture; and the risk of plaque rupture may be increased by metalloproteinases secreted by macrophages resident in the cap. These enzymes dissolve collagen, which may render the plaque more likely to rupture. Thus, the prevention of plaque weakening may constitute a means of reducing the incidence of occlusive thrombosis. Such stabilization of the plaque may be achieved by lipid lowering drugs which decrease the volume of the lipid core. Thrombosis may also occur on the plaque surface as a result of superficial injury.
Mr A Wakefield (Royal Free Hospital and School of Medicine, London) presented evidence, principally electron microscopy and immunocytochemistry, that Crohri's disease is characterized by occlusion of serosal blood vessels and local neovascularization of bowel tissues. Micrographs demonstratei:l the presence of granulomas in this microvascular bed in patients with the disease. Based on epidemiological studies, it was proposed that the trigger for these pathological events may be the measles virus. However, further work is required to confirm this theory.
Professor G D Angelini (Bristol Royal Infirmary, Bristol) discussed the use of in vitro models to study myointimal hyperplasia (MIH) following coronary artery bypass surgery using saphenous vein grafts. MIH is the principal reason for vein graft failure and this complication occurs in as many as 50% of cases 5-10 years after surgery. MIH is a process in which medial cells migrate to the luminal aspect of the blood vessel, where they continue to proliferate, thus eventually narrowing or occluding the vessel. MIH has been studied under controlled conditions by monitoring of neointernal formation and biochemical parameters in cultural whole saphenous veins. Using this system, it was established that injury sustained by surgical procedures triggers MIH. Furthermore, the culture system has been used to characterize the biochemical basis of MIH (e.g. platelet-derived growth factor (PDGF) expression and metalloproteinase synthesis and release).
Dr K L Yong (Royal Free Hospital School of Medicine,
London) gave an overview of cytokine effects on endothelial function. Different cytokines elicit different spectra of responses. Furthermore, mediators can prime the endothelium to modulate the response to subsequent stimulation. In general, cytokines act on the endothelium so as to render it more pro-thrombotic. The differential recruitment of cells by various cytokines and the central role of thrombin in inflammatory responses were also discussed.
Dr J Betteridge (University College and Middlesex
School of Medicine, London) reviewed the topic of diabetes and atherosclerosis. There is convincing evidence of premature as well as more extensive atherosclerosis in diabetics. Thus, the conventional risk factors that predict ischaemic heart disease in non-diabetics may be more important in diabetics. It is for this reason that the St Vincent Declaration recommends vigorous intervention to reduce the risk factor load in these patients. The Diabetes Control and Complications Trial also showed that intensive treatment with insulin reduced the incidence of several complications associated with insulin dependent diabetes. Abnormal vascular reactivity in hyperlipidaemics and in diabetics was also discussed. Triglycerides, and in particular post-prandial chylomicron remnants, also appear to be relevant risk factors that should be modified.
Dr A M Seddon (Kingston University, Surrey) outlined the steps that lead to the progression of atherosclerosis. Prevention of this progression was described with special reference to the St Thomas' rabbit model of genetic combined hyperlipidaernia. Some indices of atherosclerosis in this animal model improved following administration of lovastatin, a lipid lowering agent, at the early stage of 2 months. Regression of established atherosclerotic lesions was demonstrated if treatment was started at 5 months and maintained for 13 months.
Professor R M Pittilo (Kingston University, Surrey) described the harmful effects of cigarette smoke on endothelial function and morphology. Three of the numerous components of cigarette smoke were considered in greater detail: nicotine, carbon monoxide and free radicals. The latter seemed to be the most harmful of these three products of cigarette smoke.
Professor B Halliwell (King's College, London) gave a comprehensive review of the role of free radicals in mediating endothelial injury. All free radicals are not equally reactive and some of their actions are beneficial. Nitric oxide (NO), which is released by the endothelium, was considered in greater detail. It was clear that NO is not only involved in modulating vascular tone and inhibiting platelets. A role for NO has been postulated in several conditions like: reperfusion injury, septic shock, neurotoxicity and inflammation. The dietary intake of antioxidants was also considered. Markers of cell damage are likely to be the best indices of free radical activity in vivo.
Dr D P Mikhailidis (Royal Free Hospital School of Medicine, London) closed the meeting with a summing up. The endothelium is a multifunctional organ. It produces mediators that act locally or distal to the point of release. In addition, a multitude of naturally occurring and exogenous agents influence endothelial function. The endothelium may play a central role in the pathogenesis of both vascular disease and the spread of malignancies. Hence, modifying its function may be useful in the management of the diseases that currently kill most people.
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